397 related articles for article (PubMed ID: 36641456)
1. Oncolytic Parapoxvirus induces Gasdermin E-mediated pyroptosis and activates antitumor immunity.
Lin J; Sun S; Zhao K; Gao F; Wang R; Li Q; Zhou Y; Zhang J; Li Y; Wang X; Du L; Wang S; Li Z; Lu H; Lan Y; Song D; Guo W; Chen Y; Gao F; Zhao Y; Fan R; Guan J; He W
Nat Commun; 2023 Jan; 14(1):224. PubMed ID: 36641456
[TBL] [Abstract][Full Text] [Related]
2. Vesicular stomatitis virus sensitizes immunologically cold tumors to checkpoint blockade by inducing pyroptosis.
Lin J; Liu F; Gao F; Chen Y; Wang R; Wang X; Li Y; Li Q; Sun S; Li Z; Lan Y; Lu H; Guo W; Du L; Gao F; Song D; Zhao K; Guan J; He W
Biochim Biophys Acta Mol Basis Dis; 2022 Dec; 1868(12):166538. PubMed ID: 36096276
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 and oncolytic EV-D68-encoded proteases differentially regulate pyroptosis.
Shen S; Guo H; Li Y; Zhang L; Tang Y; Li H; Li X; Wang P-H; Yu X-F; Wei W
J Virol; 2024 Feb; 98(2):e0190923. PubMed ID: 38289118
[TBL] [Abstract][Full Text] [Related]
4. Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer.
van Vloten JP; Matuszewska K; Minow MAA; Minott JA; Santry LA; Pereira M; Stegelmeier AA; McAusland TM; Klafuric EM; Karimi K; Colasanti J; McFadden DG; Petrik JJ; Bridle BW; Wootton SK
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35296558
[TBL] [Abstract][Full Text] [Related]
5. A Dual-Responsive STAT3 Inhibitor Nanoprodrug Combined with Oncolytic Virus Elicits Synergistic Antitumor Immune Responses by Igniting Pyroptosis.
Su W; Qiu W; Li SJ; Wang S; Xie J; Yang QC; Xu J; Zhang J; Xu Z; Sun ZJ
Adv Mater; 2023 Mar; 35(11):e2209379. PubMed ID: 36545949
[TBL] [Abstract][Full Text] [Related]
6. The multifaceted roles of GSDME-mediated pyroptosis in cancer: therapeutic strategies and persisting obstacles.
Hu Y; Liu Y; Zong L; Zhang W; Liu R; Xing Q; Liu Z; Yan Q; Li W; Lei H; Liu X
Cell Death Dis; 2023 Dec; 14(12):836. PubMed ID: 38104141
[TBL] [Abstract][Full Text] [Related]
7. The pyroptotic role of Caspase-3/GSDME signalling pathway among various cancer: A Review.
Bhat AA; Thapa R; Afzal O; Agrawal N; Almalki WH; Kazmi I; Alzarea SI; Altamimi ASA; Prasher P; Singh SK; Dua K; Gupta G
Int J Biol Macromol; 2023 Jul; 242(Pt 2):124832. PubMed ID: 37196719
[TBL] [Abstract][Full Text] [Related]
8. Elucidating mechanisms of antitumor immunity mediated by live oncolytic vaccinia and heat-inactivated vaccinia.
Wang W; Liu S; Dai P; Yang N; Wang Y; Giese RA; Merghoub T; Wolchok J; Deng L
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34593618
[TBL] [Abstract][Full Text] [Related]
9. USP48 Stabilizes Gasdermin E to Promote Pyroptosis in Cancer.
Ren Y; Feng M; Hao X; Liu X; Li J; Li P; Gao J; Qi Q; Du L; Wang C; Wang Q; Wang Y
Cancer Res; 2023 Apr; 83(7):1074-1093. PubMed ID: 36607699
[TBL] [Abstract][Full Text] [Related]
10. An anti-mesothelin targeting antibody drug conjugate induces pyroptosis and ignites antitumor immunity in mouse models of cancer.
Wittwer NL; Staudacher AH; Liapis V; Cardarelli P; Warren H; Brown MP
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36878534
[TBL] [Abstract][Full Text] [Related]
11. ORFV: a novel oncolytic and immune stimulating parapoxvirus therapeutic.
Rintoul JL; Lemay CG; Tai LH; Stanford MM; Falls TJ; de Souza CT; Bridle BW; Daneshmand M; Ohashi PS; Wan Y; Lichty BD; Mercer AA; Auer RC; Atkins HL; Bell JC
Mol Ther; 2012 Jun; 20(6):1148-57. PubMed ID: 22273579
[TBL] [Abstract][Full Text] [Related]
12. Pyroptosis, inflammasome, and gasdermins in tumor immunity.
Ouyang X; Zhou J; Lin L; Zhang Z; Luo S; Hu D
Innate Immun; 2023 Jan; 29(1-2):3-13. PubMed ID: 36632024
[TBL] [Abstract][Full Text] [Related]
13. Improved antitumor immunity of chemotherapy in OSCC treatment by Gasdermin-E mediated pyroptosis.
Zi M; Xingyu C; Yang C; Xiaodong S; Shixian L; Shicheng W
Apoptosis; 2023 Apr; 28(3-4):348-361. PubMed ID: 36370260
[TBL] [Abstract][Full Text] [Related]
14. Ionizing Radiation Triggers the Antitumor Immunity by Inducing Gasdermin E-Mediated Pyroptosis in Tumor Cells.
Cao W; Chen G; Wu L; Yu KN; Sun M; Yang M; Jiang Y; Jiang Y; Xu Y; Peng S; Han W
Int J Radiat Oncol Biol Phys; 2023 Feb; 115(2):440-452. PubMed ID: 35918054
[TBL] [Abstract][Full Text] [Related]
15. Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade.
Marchini A; Scott EM; Rommelaere J
Viruses; 2016 Jan; 8(1):. PubMed ID: 26751469
[TBL] [Abstract][Full Text] [Related]
16. Lighting a Fire: Can We Harness Pyroptosis to Ignite Antitumor Immunity?
Zhang Z; Zhang Y; Lieberman J
Cancer Immunol Res; 2021 Jan; 9(1):2-7. PubMed ID: 33397791
[TBL] [Abstract][Full Text] [Related]
17. Inducing Pyroptosis via Gasdermin B and Gasdermin E Cleavage.
Zhou Z; Wang Y; Shao F
Methods Mol Biol; 2023; 2641():147-161. PubMed ID: 37074648
[TBL] [Abstract][Full Text] [Related]
18. mRNA lipid nanoparticle-mediated pyroptosis sensitizes immunologically cold tumors to checkpoint immunotherapy.
Li F; Zhang XQ; Ho W; Tang M; Li Z; Bu L; Xu X
Nat Commun; 2023 Jul; 14(1):4223. PubMed ID: 37454146
[TBL] [Abstract][Full Text] [Related]
19. Design and application of oncolytic viruses for cancer immunotherapy.
Ylösmäki E; Cerullo V
Curr Opin Biotechnol; 2020 Oct; 65():25-36. PubMed ID: 31874424
[TBL] [Abstract][Full Text] [Related]
20. Optimal timing of PD-1 blockade in combination with oncolytic virus therapy.
Nguyen HM; Bommareddy PK; Silk AW; Saha D
Semin Cancer Biol; 2022 Nov; 86(Pt 3):971-980. PubMed ID: 34033895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
